NPR News

For more stories on New York State, check out The Innovation Trail.
Jonathan Bush, co-founder, athenahealth, at Health Datapalooza IV, where he ...
Datapalooza: A Concept, A Conference And A Movement
Entrepreneurs, investors and data geeks descended on Washington, D.C., in pursuit of better ways to make health information useful for consumers. They urged bureaucrats to set the health data free.
Stefan Larsson serves up bison sloppy Joes and juniper-smoked bison tenderlo...
Hold The Hot Dog: National Park Visitors Can Feast On Bison Burgers
If a family vacation to Yellowstone or the Grand Tetons makes you fear for your waistline — or for your palate — there's good news: The National Park Service is revamping its menus to offer more healthful, local and fancier fare. How does a jumbo lump crab cake or almond-baked chicken sound to you?
Despite Assurances, Civil Libertarians Blast NSA Programs
In a speech Friday, President Obama tried to assure the public that the National Security Agency surveillance programs that recently came to light are all legal and have proper oversight. That assurance is not putting everyone at ease. Robert Siegel speaks with Cindy Cohn, the legal director for the Electronic Frontier Foundation.
Peter Dinklage stars as the cunning, charismatic Tyrion Lannister in HBO's h...
A Lannister Always Pays His Debts — But Do Too Many Of His Fans Watch For Free?
Watching Netflix, Hulu Plus and HBO Go with a friend or family member's password? You're not nearly alone — and that may spell trouble for providers.
Comet Shines Light on Sun Dynamics
In 2011, Comet Lovejoy traveled through the sun's corona and lived to tell the tale. But its tail was the most telling. Reporting in the journal Science, Cooper Downs, an astrophysicist at Predictive Science Inc., says that the wiggly path of the comet's tail helps explain the sun's magnetic field.
Promising Results In Early Trial of Novel MS Treatment
Reporting in the journal Science Translational Medicine researchers say a new method for essentially resetting the immune systems of patients with multiple sclerosis appears to be safe. Study co-author Stephen D. Miller of Northwestern University, describes the novel approach tested in this small, phase 1 clinical trial and explains how it might one day also be used to treat other autoimmune diseases such as type 1 diabetes.